Drug Transport And Resistance Mechanisms

Research in drug transport and resistance mechanisms investigates how cells absorb, distribute, metabolize, and excrete therapeutic compounds, as well as how organisms develop resistance to these drugs. This area explores the molecular and cellular processes underlying drug efficacy and failure, utilizing techniques from molecular biology, biochemistry, and pharmacology. Investigations focus on identifying specific transporter proteins, enzymes, and genetic mutations that influence drug pharmacokinetics and pharmacodynamics. Studies also examine the development of resistance in various contexts, including infectious diseases, cancer, and chronic conditions, with the goal of overcoming these challenges to improve treatment outcomes.

This work has direct relevance to Arkansas’s public health and economic landscape. Understanding drug transport and resistance is crucial for addressing prevalent health issues in the state, such as chronic diseases and infectious outbreaks. Furthermore, advancements in this field can support the state's growing biotechnology and pharmaceutical sectors by providing insights into drug development and optimizing existing therapies. Research efforts contribute to improving patient care and potentially reducing healthcare costs associated with ineffective treatments or the management of drug-resistant infections.

This interdisciplinary area draws upon expertise in molecular biology, genetics, pharmacology, and toxicology. The research is conducted across multiple Arkansas institutions, fostering collaboration and a broad base of scientific inquiry. Connections are evident with research in cancer, infectious diseases, and metabolic disorders, highlighting the wide-ranging impact of understanding drug transport and resistance.